Chile vs Russia: Life science patents granted, by filing office
Chile
0 patents
in 2023
Russia
0 patents
in 2023
Chile rank
48th
Russia rank
48th
Life science patents granted, by filing office over time
- Chile
- Russia
How they compare
Chile currently reports 0 patents against 0 patents in Russia, a difference of 0 patents.
Across all 44 years both countries report, Russia has been ahead every year.
Chile ranks 48th and Russia ranks 48th of 70 countries.
Russia has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Chile | Russia | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 0 patents | 0 patents | 0 patents | — |
| 1990s | 0 patents | 2,396 patents | 2,396 patents | Russia |
| 2000s | 0.4 patents | 3,743 patents | 3,742 patents | Russia |
| 2010s | 0 patents | 4,352 patents | 4,352 patents | Russia |
| 2020s | 0 patents | 2,696 patents | 2,696 patents | Russia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by filing office, Chile or Russia?
- Chile, at 0 patents against 0 patents in Russia as of 2023.
- What is the difference in life science patents granted, by filing office between Chile and Russia?
- 0 patents, with Chile ahead.
- How many years of comparable data are there for Chile and Russia?
- 44 years are reported by both, from 1980 to 2023.
- How do Chile and Russia rank globally for life science patents granted, by filing office?
- Chile ranks 48th and Russia ranks 48th of 70 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data, published as Life science patents granted, by filing office. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Patents granted within the fields of medical technology, biotechnology, and pharmaceuticals by filing office. These patents cover a wide range of innovations, such as medical devices, diagnostic methods, genetic engineering techniques, biotechnological processes and new drugs.